Cue Biopharma Inc. (CUE) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Cue Biopharma Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$21.16
+15.50% today
Market cap
$133M
Overall quality
41/100
Kronos AI 30-day
+41.3%
8 of 8 simulated paths end higher
Cue Biopharma Inc. (CUE) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $133M. It trades at $21.16, up 15.50% today. Its overall quality score is 41 out of 100, ranked against the whole US market. 1 analysts' average target of $83.00 implies +292.2% from today's price. Kronos AI's 30-day forecast is +41.3% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $83.00 |
| Low – high | $83.00 – $83.00 |
| Analysts | 1 |
| Upside to average | +292.2% |
Kronos AI 30-day forecast
| Expected close | $25.88 (+41.3%) |
| Likely range | +34.9% … +46.7% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 5 |
| Solvency | 31 |
| Growth | 88 |
| Overall | 41 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.